Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Laje, G. Articles by McMahon, F. J. Search for Related Content PubMed Citation Articles by Laje, G. Articles by McMahon, F. J. Depression Suicide Antidepressants Genetics Related Article

Genetic Markers of Suicidal Ideation Emerging During Citalopram Treatment of Major Depression

OBJECTIVE: Suicidal ideation is an uncommon symptom than can emerge during antidepressant treatment. The biological basis of treatment-emergent suicidal ideation is unknown. Genetic markers may shed light on the causes of treatment-emergent suicidal ideation and help identify individuals at high risk who may benefit from closer monitoring, alternative treatments, or specialty care. METHOD: A clinically representative cohort of outpatients with major depressive disorder who enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial were treated with citalopram under a standard protocol for up to 14 weeks. DNA samples from 1,915 participants were genotyped for 768 single-nucleotide polymorphisms in 68 candidate genes. Allele and genotype frequencies were compared between the 120 participants who developed treatment-emergent suicidal ideation and those who did not. RESULTS: Two markers were significantly associated with treatment-emergent suicidal ideation in this sample (marker rs4825476, p=0.0000784, odds ratio=1.94; permutation p=0.01; marker rs2518224, p=0.0000243, odds ratio=8.23; permutation p=0.003). These markers reside within the genes GRIA3 and GRIK2, respectively, both of which encode ionotropic glutamate receptors. CONCLUSIONS: Markers within GRIK2 and GRIA3 were associated with treatment-emergent suicidal ideation during citalopram therapy. If replicated, these findings may shed light on the biological basis of this potentially dangerous adverse event and help identify patients at increased risk.

Related Article:

In This Issue
Am J Psychiatry 2007 164: A34. [Full Text] [PDF]

This article has been cited by other articles:

				G. Laje, R. H. Perlis, A. J. Rush, and F. J. McMahon Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results Psychiatr Serv, November 1, 2009; 60(11): 1446 - 1457. [Abstract] [Full Text] [PDF]

				T. R. Insel and P. S. Wang The STAR*D Trial: Revealing the Need for Better Treatments Psychiatr Serv, November 1, 2009; 60(11): 1466 - 1467. [Abstract] [Full Text] [PDF]

				O. Malkesman, D. R. Austin, G. Chen, and H. K. Manji Reverse translational strategies for developing animal models of bipolar disorder Dis. Model. Mech., May 1, 2009; 2(5-6): 238 - 245. [Abstract] [Full Text] [PDF]

				H. I Weisberg, V. C Hayden, and V. P Pontes Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? Clinical Trials, April 1, 2009; 6(2): 109 - 118. [Abstract] [PDF]

				A. MENKE, S. LUCAE, S. KLOIBER, S. HORSTMANN, T. BETTECKEN, M. UHR, S. RIPKE, M. ISING, B. MuLLER-MYHSOK, F. HOLSBOER, et al. Genetic Markers Within Glutamate Receptors Associated With Antidepressant Treatment-Emergent Suicidal Ideation Am J Psychiatry, July 1, 2008; 165(7): 917 - 918. [Full Text] [PDF]

				D. F. LEVINSON Genetics and Suicidal Ideation During Antidepressant Treatment Am J Psychiatry, March 1, 2008; 165(3): 395 - 395. [Full Text] [PDF]

				Possible Biologic Basis to SSRI-Related Suicidal Ideation Journal Watch Psychiatry, January 7, 2008; 2008(107): 1 - 1. [Full Text]

				Bibliography for Major Depressive Disorder and Suicide Focus, January 1, 2008; 6(1): 58 - 62. [Full Text] [PDF]

				M. Crandall Suicide: scientific overview and relevance for trauma care providers Trauma, July 1, 2007; 9(3): 213 - 220. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us